DSMC's Comprehensive Cancer Center is at the forefront of patient-centered cancer care and will be the first top-tier general hospital in South Korea to introduce the ProTom Radiance 330 proton therapy system. This development will make DSMC the country's third proton center, after the National Cancer Center and Samsung Medical Center, and the first located outside a metropolitan area, broadening access to cutting-edge cancer treatment for patients in the region.

By combining RayStation and RayCare, the center will integrate treatment planning and oncology information management into one workflow, including advanced functionalities such as synchrotron-based proton pencil beam scanning therapy. This technique allows for highly precise radiation delivery while minimizing exposure to surrounding healthy tissue. It is particularly effective for cancers in sensitive areas such as the head and neck, spinal cord, and in pediatric patients, helping reduce side effects and improve patients' quality of life.

CHI-HEUM CHO, President, Keimyung University Dongsan Medical Center: "We are pleased to introduce RayStation and RayCare at the new proton therapy center at Keimyung University Dongsan Medical Center. These advanced systems will enable the establishment of a more precise and efficient cancer treatment framework, setting new standards for oncology care that are competitive not only within Korea but also on a global scale."

Johan Löf, founder and CEO, RaySearch: "South Korea is an exciting market with some of the world's most advanced radiation therapy facilities, and we see strong interest in RayStation and RayCare in the region. We are honored by the trust placed in us by DSMC and look forward to continued collaboration with their organization."

About Keimyung University Dongsan Medical Center

Keimyung University Dongsan Medical Center (DSMC) traces its origin to the 1899 founding of Jaejungwon by missionary Woodbridge O. Johnson, who introduced Western medicine to the Daegu region. Over decades of public health work, medical missions, and expansion, it became Dongsan Presbyterian Hospital before merging with Kei Myung University in 1982. Today, DSMC is a leading medical institution with over 1,000 beds and 3,500 staff, recognized for advanced care, education, research, and international outreach through its Seongseo hospital and specialized centers for critical illnesses. DSMC's Comprehensive Cancer Center provides advanced, patient-centered cancer care in response to Korea's growing cancer burden, with over 120,000 new cases diagnosed annually. The center integrates prevention, multidisciplinary research, and comprehensive data management to address the complex needs of patients and families. Through close collaboration among cancer specialists, each patient receives a tailored treatment plan-including surgery, chemotherapy, or radiation therapy - ensuring the most effective and personalized approach to care.

About RaySearch

RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation®* treatment planning system (TPS) and the oncology information system (OIS) RayCare®*. The most recent additions to the RaySearch product line are RayIntelligence® and RayCommand®*. RayIntelligence is an oncology analytics system (OAS) which enables cancer clinics to collect, structure and analyze data. RayCommand, a treatment control system (TCS), is designed to link the treatment machine and the treatment planning and oncology information systems. RaySearch's software has been sold to over 1,100 clinics in 47 countries. The company was founded in 2000 as a spin-off from the Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003 (STO: RAY B). More information is available at raysearchlabs.com.
 

About RayStation

RayStation®* is a flexible, innovative treatment planning system, chosen by many leading cancer centers worldwide. It combines unique features such as unmatched adaptive therapy capabilities, multi-criteria optimization, market-leading algorithms for treatment plan optimization for HDR brachytherapy and external beam therapy with photons, electrons, and protons, as well as helium and carbon ions. RayStation supports a wide range of treatment machines, providing one control center for all treatment planning needs and ensuring centers get greater value from existing equipment. RayStation also seamlessly integrates with RayCare®*. By harmonizing the treatment planning, the care of cancer patients worldwide is improved. 

About RayCare

The RayCare®* oncology information system (OIS) is designed to support the many complex logistical challenges faced by today's oncology clinics. RayCare is closely integrated with RayStation®* and provides seamless access to all the powerful planning tools in RayStation and RayCommand®. The system efficiently coordinates activities in radiation therapy and offers advanced features for clinical workflow automation, and adaptive radiation therapy. RayCare responds to the demand from clinics for a more user-friendly and workflow-oriented information system that can support the cancer care of the future.

* Subject to regulatory clearance in some markets. 

For more information, please contact: 

Johan Löf, founder and CEO, RaySearch Laboratories AB

Telephone: +46 (0) 8 510 530 00 

Carolina Strömlid, Head of Investor Relations, RaySearch Laboratories AB

Telephone: +46 (0) 708 807 173 

ir@raysearchlabs.com

Learn more about us on:
LinkedIn

YouTube